Abstract
dc:descriptionThe cardiovascular diseases ( coronary artery disease, cerebrovascular disease, peripheral artery disease ) are the leading cause of death globally. As a result there is a great need for vascular grafts to be used in bypass surgeries. The currently available grafts are synthetic and made of a polymeric material. Despite the advances made in synthetic graft design and construction, still there are problems that often lead to graft failure, especially in grafts less than 6mm or in areas with low blood flow, mostly because of thrombosis. Moreover synthetic grafts are prone to infection. By seeding functional cells on biodegradable scaffolds tissue engineering has become a promising approach for generating a biocompatible vessel graft with growth potential. To date tissue engineered blood vessels (TEBV) can be constructed in vitro and used to repair vessel defects in animal models. Furthermore certain groups have even progressed to the point of implanting TEBVs n humans, with promising results. The purpose of this review is to outline the principles of blood vessel engineering and to present the current status in cell seeding, biodegradable scaffolds, and construction technology as well as the achievements in clinical practice. The remaining challenges are also discussed.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Σουλτάνης Κωνσταντίνος Μάριος
Rights
- Language dc:language
- English
Identifiers
dc:identifier.*- Identifier
- uoadl:1315205